Topics

Two Months To Add Two Words – Biosimilar Supplement Review Times May Be Hindering Uptake

15:03 EDT 1 May 2019 | SCRIP

Biosimilar supplement approvals by the US FDA take on average about five months as sponsors request easier and quicker ways...

      

Related Stories

 

Original Article: Two Months To Add Two Words – Biosimilar Supplement Review Times May Be Hindering Uptake

NEXT ARTICLE

More From BioPortfolio on "Two Months To Add Two Words – Biosimilar Supplement Review Times May Be Hindering Uptake"

Quick Search

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...